Literature DB >> 35454033

Pathological Evaluation of Rectal Cancer Specimens Using Micro-Computed Tomography.

Masao Yoshida1,2, Emine Cesmecioglu1,3, Canan Firat1, Hirotsugu Sakamoto4, Alexei Teplov1, Noboru Kawata2, Peter Ntiamoah1, Takashi Ohnishi1, Kareem Ibrahim1, Efsevia Vakiani1, Julio Garcia-Aguilar5, Meera Hameed1, Jinru Shia1, Yukako Yagi1.   

Abstract

Whole-block imaging (WBI) using micro-computed tomography (micro-CT) allows the nondestructive reconstruction of a three-dimensional view of tissues, implying that WBI may be used for accurate pathological evaluation of patients with rectal cancer. HOWEVER, the clinical impact of this approach is unclear. We aimed to clarify the efficacy of WBI in the whole-mount specimens of locally advanced rectal cancer. A total of 237 whole-mount formalin-fixed paraffin-embedded blocks from 13 patients with rectal cancer who underwent surgical treatment were enrolled and scanned with micro-CT to generate three-dimensional images. WBI was evaluated following the conventional pathological review of the corresponding whole-slide imaging (WSI). WBI identified all tumor sites detected using WSI. Furthermore, WBI revealed one additional tumor site, which was not detected using WSI. Tumor resection margin was significantly closer to the soft-tissue edge when measured using WBI (7.7 mm vs. 6.6 mm, p < 0.01). Seventy-six percent of tumor deposits on WSI were changed according to the evidence of tumor interaction with the surrounding tissues confirmed using WBI. Furthermore, WBI revealed 25 additional lymph nodes, six of which were metastatic. The combination of conventional hematoxylin and eosin-stained imaging and WBI may contribute to an accurate pathological assessment.

Entities:  

Keywords:  micro-CT; rectal cancer; three-dimensional images; whole-block imaging

Year:  2022        PMID: 35454033      PMCID: PMC9044748          DOI: 10.3390/diagnostics12040984

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  45 in total

1.  Circumferential margin involvement after total mesorectal excision for mid or low rectal cancer: are all R1 resections equal?

Authors:  A Beaufrère; N Guedj; L Maggiori; A Patroni; P Bedossa; Y Panis
Journal:  Colorectal Dis       Date:  2017-11       Impact factor: 3.788

2.  Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.

Authors:  Sunil V Patel; Campbell S Roxburgh; Efsevia Vakiani; Jinru Shia; J Joshua Smith; Larissa K Temple; Philip Paty; Julio Garcia-Aguilar; Garrett Nash; Jose Guillem; Abraham Wu; Marsha Reyngold; Martin R Weiser
Journal:  J Surg Oncol       Date:  2016-09-19       Impact factor: 3.454

3.  ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

Authors:  H J Schmoll; E Van Cutsem; A Stein; V Valentini; B Glimelius; K Haustermans; B Nordlinger; C J van de Velde; J Balmana; J Regula; I D Nagtegaal; R G Beets-Tan; D Arnold; F Ciardiello; P Hoff; D Kerr; C H Köhne; R Labianca; T Price; W Scheithauer; A Sobrero; J Tabernero; D Aderka; S Barroso; G Bodoky; J Y Douillard; H El Ghazaly; J Gallardo; A Garin; R Glynne-Jones; K Jordan; A Meshcheryakov; D Papamichail; P Pfeiffer; I Souglakos; S Turhal; A Cervantes
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 4.  The staging of colorectal cancer: 2004 and beyond.

Authors:  Carolyn C Compton; Frederick L Greene
Journal:  CA Cancer J Clin       Date:  2004 Nov-Dec       Impact factor: 508.702

5.  Serum hsa-miR-30e As a Potential Biomarker to Predict the Effect of Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer.

Authors:  Weiwei Chen; Wenling Wang
Journal:  Genet Test Mol Biomarkers       Date:  2021-11

Review 6.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

7.  Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study.

Authors:  Fabian M Troschel; Ravi V Gottumukkala; Daniel DiCorpo; Julia Mario; Harald C Ott; Cameron D Wright; Ashok Muniappan; Michael Lanuti; Kai Yang; JoAnne O Shepard; Valentina Nardi; James S Michaelson; Lida P Hariri; Florian J Fintelmann
Journal:  Arch Pathol Lab Med       Date:  2018-11-20       Impact factor: 5.534

8.  Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.

Authors:  Hak-Mien Quah; Joanne F Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Leonard B Saltz; Karyn A Goodman; Bruce D Minsky; W Douglas Wong; Martin R Weiser
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

9.  Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Al B Benson; Alan P Venook; Mahmoud M Al-Hawary; Lynette Cederquist; Yi-Jen Chen; Kristen K Ciombor; Stacey Cohen; Harry S Cooper; Dustin Deming; Paul F Engstrom; Jean L Grem; Axel Grothey; Howard S Hochster; Sarah Hoffe; Steven Hunt; Ahmed Kamel; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Jeffrey Meyerhardt; Mary F Mulcahy; James D Murphy; Steven Nurkin; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Evan Wuthrick; Kristina M Gregory; Lisa Gurski; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2018-07       Impact factor: 11.908

10.  The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery.

Authors:  Kuo Zheng; Nanxin Zheng; Cheng Xin; Leqi Zhou; Ge Sun; Rongbo Wen; Hang Zhang; Guanyu Yu; Chenguang Bai; Wei Zhang
Journal:  Gastroenterol Res Pract       Date:  2020-03-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.